FDA Approves Lilly’s Once-Weekly Insulin for Type 2 Diabetes
The U.S. Food and Drug Administration has approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type 2 diabetes. The decision gives patients a long-acting option that can replace daily basal injections with…
